Concepedia

David Bushnell

DB

Statistics

Publications

123

Citations

9.8K

H-Index

43

Active since

1963

Affiliations

Lockheed Martin (United States)(Current)

University of Iowa

University of Iowa Hospitals and Clinics

Science Research Laboratory

Edward Hines, Jr. VA Hospital

David Bushnell is an author at Lockheed Martin (United States) specializing in medicine, oncology, and engineering.

Publications per year

1963–2024

123

Publications

123

Phase 3 Trial of <sup>177</sup> Lu-Dotatate for Midgut Neuroendocrine Tumors

Jonathan Strosberg, Ghassan El‐Haddad, Edward M. Wolin et al. · New England Journal of Medicine · 2017 · 3.2K citations · Full text

Medicine, Oncology, Pharmacology +17

NANETS Treatment Guidelines

Matthew H. Kulke, Lowell Anthony, David Bushnell et al. · Pancreas · 2010 · 571 citations · Full text

Medicine, Oncology, Surgery +15

The NANETS Consensus Guideline for the Diagnosis and Management of Neuroendocrine Tumors

J. Philip Boudreaux, David S. Klimstra, Manal M. Hassan et al. · Pancreas · 2010 · 532 citations

Medicine, Oncology, Surgery +17

Health-Related Quality of Life in Patients With Progressive Midgut Neuroendocrine Tumors Treated With <sup>177</sup>Lu-Dotatate in the Phase III NETTER-1 Trial

Jonathan Strosberg, Edward M. Wolin, Beth Chasen et al. · Journal of Clinical Oncology · 2018 · 389 citations

Medicine, Nuclear Medicine, Oncology +13

<sup>90</sup>Y-Edotreotide for Metastatic Carcinoid Refractory to Octreotide

David Bushnell, Thomas M. O’Dorisio, M. Sue O’Dorisio et al. · Journal of Clinical Oncology · 2010 · 304 citations · Full text

Medicine, Oncology, Pharmacotherapy +17

1–5 of 123